Jump to content
RemedySpot.com

Hard to find, HIV-positive children for crucial study

Rate this topic


Guest guest

Recommended Posts

Guest guest

Hard to find, HIV-positive children for crucial study

Jun 17, 2009 at 2343 hrs IST Pune Researchers at B J Medical College (BJMC)

are facing a challenging task of identifying HIV positive babies and children,

in the age group of six months to three years, who have not received any

treatment so far. At least 21 are to be included in a multi-centric trial aimed

at finding newer and effective HIV drug regimen.

Locating such babies and children for the study has become an extremely

difficult task, say researchers at BJMC, the only medical college in the country

selected by the National Institutes of Health, USA, to set up a Clinical Trial

Unit (CTU) for multi-centric studies on HIV prevention in mother and child.

As per the national policy and National AIDS Control Organisation (NACO)

guidelines, the single-dose Nevirapine (NVP) remains a practical choice for

prevention of HIV transmission from mother to child in areas with minimal

medical resources, said CTU vice-president Dr Renu Bharadwaj. " Without

treatment, around 15-30 per cent of the babies born to HIV positive women will

become infected with HIV during pregnancy or delivery. "

Most HIV-infected pregnant women take at least one dose of NVP right before or

during delivery and the baby also gets a dose of the drug. Researchers at BJMC,

which has been one of the multi-centric sites for a trial on lowering the rate

of HIV transmission to infants, are also raising concerns over the issue of drug

resistance. " There is a likelihood of children being resistant to the drug and

who could react better to a combination of drugs, " said Dr Nishi Suryavanshi, a

scientist working with the project.

A study has also been proposed as part of the International Maternal Paediatric

Adolescent AIDS Clinical Trials Group with the mission to develop and evaluate a

safe and cost-effective approach to the interruption of mother to infant

transmission of HIV. " We want to enroll at least 21 HIV children who have not

been exposed to any drug. They will be involved in the clinical trial after

parents or guardians give their consent, " said Bharadwaj.

The researchers are reaching out to civic and private hospitals and NGOs apart

from tapping rural doctors in their search for infants and children (6 months to

3 years), who are HIV positive and have not received any treatment. " We are

appealing to paediatricians who treated sick babies and HIV-positive mothers who

had not received any treatment, so that the children can be registered for the

project, " said Bharadwaj.

AIDS vaccine trial Phase 1 on

The National AIDS Research Institute, Pune, and the Tuberculosis Research

Centre, Chennai, too had faced a huge challenge in enrolment of volunteers for

the AIDS vaccine trial. " It is very difficult to enlist volunteers. But the

process is under way and phase 1 of the trial has begun, " say top scientists at

both the institutes.

In Chennai, the TRC banked on Y R G Care centre to conduct meetings with the

communities and get more volunteers. A total of 32 volunteers are required (16

each at NARI and TRC) for phase 1 of the trial. " We are nearing completion of

enrolment, " the scientists said.

The trial uses a DNA-based vaccine candidate ADVAX to prime the immune system.

http://www.expressindia.com/latest-news/hard-to-find-hivpositive-children-for-cr\

ucial-study/477482/

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...